Chris Schelling is the founder of Acer Therapeutics. Acer Therapeutics has raised $17M in total funding. Latest round: Growth.
Chris Schelling is the Co-Founder, CEO, and Board Member of Acer Therapeutics, a biopharmaceutical company that develops treatments for serious diseases. He is a significant owner of the company's stock and has provided direct capital infusions, including a $1 million promissory note in 2023. He has been with the company since its formation in 2017 after the merger of Opexa Therapeutics and Acer Therapeutics.
Full founder directory · Investor directory · Company funding database · Fundraising library